Alterations should be produced cautiously and also the frequency of blood glucose monitoring should be amplified. Changes in concomitant oral antidiabetic therapy may very well be required.Temporary Protection Assertion: Failure to make use of the Dexcom Constant Glucose Monitoring System and its components in accordance with the Guidance for use